http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1114046-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e6c297128af07574e9d29c1855289fc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5be1bf05dadb2d231597bc49429e1b4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5c4cb5dd28a60e3ea34e906938989b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af31c4d4745f58f8d77702fb4c0c9763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e6d007b29782fe6d86b0a4a37c766df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2371c943af84e89136d661ec53b94954
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73081079aab4dfe00c56eb2d27d413b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ef7f9b45e78b3f05c0ebc49d454323c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db29f28dfa7e0c3bcd535b7e8c01859
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cd8e2f6fe58dd39f05e25a9f82c4f5a
publicationDate 2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1114046-T1
titleOfInvention PHARMACEUTICAL COMPOSITION CONTAINING FIREWORK MOMETAZONE
abstract Pharmaceutical composition for application to the skin, containing 0.01% - 0.2% (w / w) mometasone furoate, 10% - 90% (w / w,) water and a combination of at least one aromatic alcohol and at least one solvent selected from a first group, consisting of C8-C22 chain alkoxylated fatty alcohols, C8-C22 chain alkoxylated and non-alkoxylated fatty acids and C2-alkoxylated carboxylic acid alkoxylated carboxylic acid esters and / or a second group, to which the multiverse belongs C2-C10 chain aliphatic alcohols, C2-C4 chain polyalkyl alcohols, and non-alkoxylated ethers of the above-mentioned multivalent aliphatic alcohols and polyalkylene glycols, wherein the further ether component has a C-terminal length;
priorityDate 2006-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244

Total number of triples: 36.